Navigation Links
Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
Date:10/16/2008

COPENHAGEN, October 16 /PRNewswire-FirstCall/ -- Exiqon today announces the adoption of the name Exiqon Diagnostics for its U.S. subsidiary to signal the company's commitment to expanding its business to a broad offering in molecular and cellular-based diagnostics that guide treatment decisions in oncology.

Exiqon is pleased to announce the adoption of a new name for their clinical laboratory diagnostics business, Exiqon Diagnostics. This progressive change will demonstrate the continuity of the entire Exiqon organization and is an important symbol of Exiqon's commitment to transform Oncotech from its leading position in chemotherapy resistance testing to being the leader in personalized cancer diagnostics with a broad menu of molecular and cellular based assays for solid tumor diagnostics.

"We are excited to adopt this name for our business as it will show to our customers and their patients that Oncotech is undergoing a positive transformation that will lead to a more valuable and comprehensive offering," commented Lars Kongsbak, President and CEO of Exiqon A/S.

Since the acquisition, Exiqon has been integrating Oncotech and Exiqon to form "One Company" with multiple business divisions. Oncotech represents Exiqon's diagnostics division and as part of this integration plan, Exiqon is adopting the new name to better reflect this role within the company. The Oncotech name will continue to remain visible through the re-branding of the Extreme Drug Resistance assay as the Oncotech EDR Assay. As Exiqon Diagnostics, the business unit will be leveraging the broad and powerful intellectual property and R&D pipeline from Exiqon to establish a menu of innovative diagnostic tests that guide physicians in selecting the most appropriate therapies for their patients.

Going forward, Exiqon will create a parallel nomenclature for its three revenue driving businesses: our diagnostic business will conduct its business under the name Exiqon Diagnost
'/>"/>

SOURCE Exiqon A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
2. Report Regarding the Managements and Closely Related Parties Transactions With Securities in Exiqon A/S
3. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
4. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
5. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
6. Exiqon: Major Shareholder Announcement
7. Vasogen Announces Third Quarter 2008 Results
8. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
9. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
10. Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services
11. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... LOS ANGELES , April 20, 2015  "Everybody ... says. "What we do to patients is frankly brutal. We,ve ... been in a cancer ward, or witnessed a loved ... then you,ve witnessed firsthand the devastation chemotherapy and other ... make most people want to give up and succumb ...
(Date:4/20/2015)... , April 20, 2015 /CNW/ - Portage Biotech Inc. ... Exchange: PBT.U), is pleased to announce that its wholly ... collaborative research study that showed one of its proprietary ... in brain tissue through inhibition of NFkB signalling even ... The permeability of the blood brain barrier (BBB) ...
(Date:4/20/2015)... , April 20, 2015   Meditope Biosciences, ... using its proprietary technology, today announced presentation of data ... the development of antibody-drug conjugates (ADCs). The data were presented ... taking place April 18-22 in Philadelphia ... these data which point to the many commercial applications ...
(Date:4/20/2015)... Whitehouse Laboratories is pleased and overly excited to ... and Drug Administration (FDA) inspection and received no observations ... compliance inspection, as based upon 21CFR Parts 210 and ... and was granted NAI (no action indicated) status. The ... Manufacturing Practice (GMP) quality system required by the regulatory ...
Breaking Biology Technology:Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3
... with standardized clones , , Rebecca L. ... Wynne Vilma Nioko ,Leonardo DeLeon SanDEe Soares ... Spencer Stevens Chris Hansen Brian Schilling ,Phenogenex ... a single dual- expression vector. These clones eliminate the ...
... , Mycoplasma PCR Primer Set for fast and ... S. Arrington ,Yale University , D. R. Staggs ,Genetic ... of mammalian cell cultures can substantially,reduce the potency of ... contamination before the optimal amounts of LipoTAXI ...
... with the Big Blue transgenic,rodent mutation assay ... Glickman ,Centre for Environmental Health, University of Victoria, Victoria, ... transgenic rodent mutation,assay,* which carries the E. coli ... is easy to study mutations in male,and female mice ...
Cached Biology Technology:Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 2Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 3Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 4Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 5Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 6Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 2Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 2Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 4Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 5Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 6Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 7
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... cycle and, in most cases, they have evolved a "circadian ... functioning has been shown to have important metabolic consequences for ... effects on health; for example lack of sleep is linked ... affect the ability to control body weight. Scientists from ...
... A unique study of the white-throated sparrow has identified a ... behaviors in the wild to variation in their genome. ... ( PNAS ) is publishing the results of the experiments, ... University,s Department of Psychology. The research, which ...
... Mass. Plant cell biologist Magdalena Bezanilla at the ... grant from the National Science Foundation to further her ... particular how molecules secreted by cells help to determine ... as the difference between building a short round adobe ...
Cached Biology News:The internal clock and feeding rhythm set the pace of the liver 2Wild sparrow study traces social behaviors in the field to specific gene 2Wild sparrow study traces social behaviors in the field to specific gene 3Wild sparrow study traces social behaviors in the field to specific gene 4Plant cell growth studies funded by NSF grant at UMass Amherst 2
Request Info...
... Express Cloning Checker Kits provide two highly ... transformation without time-consuming plasmid preparation. By using ... all you need to do is to ... directly from the transformation plates into the ...
The Proteome Profiler Human Phospho-MAPK Array Kit contains 4 membranes - each spotted in duplicate with 23 different MAPK antibodies....
...
Biology Products: